04:47 PM EDT, 05/06/2024 (MT Newswires) -- Jeffrey Robert Ajer, Executive Vice President, Chief Commercial Officer, on May 02, 2024, sold 5,000 shares in Biomarin Pharmaceutical ( BMRN ) for $414,550. Following the Form 4 filing with the SEC, Ajer has control over a total of 66,767 shares of the company, with 66,767 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048477/000104847724000073/xslF345X03/wk-form4_1715028037.xml ...

04:48 PM EDT, 05/06/2024 (MT Newswires) -- James E Bunn, President, Global Equities and Investment Banking, RJA, on May 03, 2024, sold 11,095 shares in Raymond James Financial ( RJF ) for $1,380,614. Following the Form 4 filing with the SEC, Bunn has control over a total of 48,938 shares of the company, with 46,977 shares held directly and 1,961...

04:50 PM EDT, 05/06/2024 (MT Newswires) -- Gatos Silver ( GATO ) was up near 1% in US after-hours trading on Monday as it reported an increase in its overall first-quarter profit, but in a drop in net income for the Los Gatos Joint Venture over the same period. It had overall first quarter net income of US$2.5 million, or...

May 6 (Reuters) - The U.S. FDA's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder, Lykos Therapeutics said on Monday. This would be the first FDA panel of outside experts to review a potential new PTSD treatment in 25 years. PTSD is a disorder caused...